AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

SITAGLIPTIN 50 Mg ;

11 registrations across 1 African market— 11 active

Markets with SITAGLIPTIN 50 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Ramsitaglip 50mg
Film Coated Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Januvia
Film Coated Tablets
🇪🇬EgyptMERCK SHARP and DOHME SCIENTIFIC OFFICEactive
Januvia
Film Coated Tablets
🇪🇬EgyptMERCK SHARP&DOHME SCIENTIFIC OFFICEactive
Chemisitaglip 50 mg
Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Zucat 50 mg
Film Coated Tablets
🇪🇬EgyptViatris Egyptactive
Cozasita 50 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Cozasita 50 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Zucat 50 mg
Film Coated Tablets
🇪🇬EgyptViatris Egyptactive
Ramsitaglip 50mg
Film Coated Tablets
🇪🇬EgyptThe Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"active
Januvia
Film Coated Tablets
🇪🇬EgyptMERCK SHARP&DOHME SCIENTIFIC OFFICEactive
Chemisitaglip 50 mg
Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive

SITAGLIPTIN 50 Mg ; in Africa — Regulatory Overview

SITAGLIPTIN 50 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.